Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of General Virology|March 21, 2001
A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatednessFuminaka Sugauchi, Masashi Mizokami, Etsuro Orito, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2023
BRAF V600E-mutated Colorectal Neuroendocrine Carcinoma Effectively Treated with a Chemotherapy Protocol for BRAF-mutated Metastatic Colorectal CancerSeira Owaki, Yoshinori Mori, Shunsuke Nakai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Coexpression of organic anion-transporting polypeptides 1B3 and multidrug-resistant proteins 2 increases the enhancement effect of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid on hepatocellular carcinoma in magnetic resonance imagingYoshihide Kimura, Shinya Sato, Eiichi Hitomi, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|October 27, 2020
Efficacies of first and second tumor necrosis factor inhibitors in refractory ulcerative colitis patients in real-world practiceYuka Marutani, Tsutomu Mizoshita, Tomoya Sugiyama, et al.
Case Reports in Gastroenterology|June 12, 2019
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab TreatmentTaketo Suzuki, Tsutomu Mizoshita, Tomoya Sugiyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 8, 2022
Efficacy of minocycline hydrochloride aspiration sclerotherapy with additional monoethanolamine oleate aspiration sclerotherapy for symptomatic hepatic cystsYoshihide Kimura, Kei Fujiwara, Kentaro Matsuura, et al.
Oncology|March 30, 2025
The Effectiveness of Long-Term Continuation of Atezolizumab plus Bevacizumab in Patients Receiving Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: A Multicenter StudyTakanori Suzuki, Kiyoto Narita, Kentaro Matsuura, et al.
Oncology|October 20, 2024
Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter StudyDaisuke Kato, Takanori Suzuki, Kentaro Matsuura, et al.
Oncology|May 26, 2025
Number of Tumors Stratifies the Therapeutic Response to Atezolizumab plus Bevacizumab Therapy in Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: A Multicenter AnalysisTakanori Suzuki, Kentaro Matsuura, Daisuke Kato, et al.
Cancer Medicine|December 22, 2023
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysisTakanori Suzuki, Kentaro Matsuura, Yuta Suzuki, et al.
Pageof 4